Company / Cash & Equivalents
Evolus, Inc. Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$53.8M
FY2025
5-year range
$53.8M / $146.3M
FY2021-FY2025
Trend
-38.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 7 years, ranging from $54M in FY2025 to $146M in FY2021.
Based on SEC 10-K filings.
$54M in FY2025 with a 5-year CAGR of -12.1%.
Declined from $63M to $54M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- -12.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -12.1%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 38.1% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.8M | -38.1% |
| FY2024 | $87.0M | +38.4% |
| FY2023 | $62.8M | +16.5% |
| FY2022 | $53.9M | -63.1% |
| FY2021 | $146.3M | +42.6% |
| FY2020 | $102.6M | -6.7% |
| FY2019 | $109.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026